FDA Adverse Event Injury Summary report: N

ALYTE Y-MESH GRAFT

MDR report key: 2960908 · Received February 11, 2013

Report

Report Number
1018233-2013-00369
Event Type
Injury
Date Received
February 11, 2013
Report Date
January 14, 2013
Manufacturer
C.R. BARD, INC. (COVINGTON)
Product Code
OTO
PMA / PMN Number
K101722
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS NOT RETURNED. THE LOT NUMBER IS UNKNOWN THEREFORE, THE DEVICE HISTORY RECORD COULD NOT BE REVIEWED. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICE CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE ADVERSE EVENTS: "COMPLICATIONS ASSOCIATED WITH THE PROPER IMPLANTATION OF THE ALYTE Y-MESH GRAFT MAY INCLUDE, BUT ARE NOT LIMITED TO THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS INCLUDING: POSTOPERATIVE HEMATOMA, SEROMA, ABSCESS OR FISTULA FORMATION, OR SCARRING WHICH MAY OCCUR FOLLOWING THE IMPLANT PROCEDURE; URINARY RETENTION, BLADDER OUTLET OBSTRUCTION AND OTHER VOIDING AND DEFECATORY DYSFUNCTIONS. THESE CONDITIONS MAY BE ASSOCIATED WITH OVER-CORRECTION/TOO MUCH TENSION PLACED ON THE IMPLANT; PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, URETHRA, RECTUM, OR ANY VISCERA, WHICH MAY OCCUR DURING THE IMPLANTATION PROCEDURE; IRRITATION AT THE OPERATIVE WOUND SITE WHICH MAY ELICIT A FOREIGN BODY RESPONSE THAT LEADS TO WOUND DEHISCENCE, INFLAMMATION AND/OR INFECTION; EXTRUSION THROUGH VAGINAL EPITHELIUM OR EROSION INTO SURROUNDING VISCERA AND/OR MUCOSA; INFLAMMATION, SENSITIZATION, PAIN, DYSPAREUNIA, SCARIFICATION, CONTRACTION, DEVICE MIGRATION AND FAILURE OF THE PROCEDURE RESULTING IN RECURRENCE OF VAGINAL WALL PROLAPSE. URINARY INCONTINENCE (STRESS AND URGE)." (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED BY THE PATIENT'S DOCTOR THAT AS A RESULT OF HAVING THE PRODUCT IMPLANTED, THE PATIENT HAS EXPERIENCED MESH EROSION, VAGINAL BLEEDING AND IS BEING TREATED WITH VAGINAL ESTROGEN. THE DOCTOR HAS REPORTED THAT HE HAS SEEN A DEFECT IN THE VAGINA IN THE APEX WITH APPARENT MESH EROSION. HE HAS SCHEDULED THE PATIENT FOR AN EXAM UNDER ANESTHESIA WITH EXPECTATION OF MESH REMOVAL, FRESHENING THE EDGES AND REAPPROXIMATING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
59696 ALYTE Y-MESH GRAFT OTO C.R. BARD, INC. (COVINGTON) NA UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention